# Medha Barbhaiya

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/medha-barbhaiya/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,352 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 35 |
| i10-index | 63 |
| OpenAlex ID | https://openalex.org/A5060417778 |
| ORCID iD | 0000-0002-6670-7696 |
| Works | 106 |

## Researcher papers

- [2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of/)
- [The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria](https://scholariq.org/papers/the-2023-scp-acr-scp-scp-eular-scp-antiphospholipid-syndrome-classification/)
- [2023 ACR/EULAR antiphospholipid syndrome classification criteria](https://scholariq.org/papers/2023-acr-eular-antiphospholipid-syndrome-classification-criteria/)
- [2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of-2/)
- [Environmental exposures and the development of systemic lupus erythematosus](https://scholariq.org/papers/environmental-exposures-and-the-development-of-systemic-lupus-erythematosus/)
- [Adverse Effects of Low-Dose Methotrexate](https://scholariq.org/papers/adverse-effects-of-low-dose-methotrexate/)
- [Understanding the role of environmental factors in the development of systemic lupus erythematosus](https://scholariq.org/papers/understanding-the-role-of-environmental-factors-in-the-development-of-systemic/)
- [Racial/Ethnic Variation in All‐Cause Mortality Among United States Medicaid Recipients With Systemic Lupus Erythematosus: A Hispanic and Asian Paradox](https://scholariq.org/papers/racial-ethnic-variation-in-all-cause-mortality-among-united-states-medicaid/)
- [The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort](https://scholariq.org/papers/the-adjusted-global-antiphospholipid-syndrome-score-agapss-and-the-risk-of/)
- [Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses' Health Study cohorts](https://scholariq.org/papers/cigarette-smoking-and-the-risk-of-systemic-lupus-erythematosus-overall-and-by/)
- [Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries](https://scholariq.org/papers/disparities-in-lupus-and-lupus-nephritis-care-and-outcomes-among-us-medicaid/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.